Correspondingly, therapeutic strategies targeting DUX4-mediated pathways are multifaceted, and targeting the pathways activated by DUX4 could disrupt these embryonic programs, potentially hindering tumor growth and dissemination. Here, DUX4 is linked to neoplasm.